SUNNYVALE, Calif.--(BUSINESS WIRE)--IntraOp Medical Corporation (OTCBB: IOPM) today announced that it entered into an agreement with Southwest Florida Dermrad, LLC™ (Dermrad™) in Fort Myers, Florida, to provide a Mobetron that will treat skin cancer patients with electron-beam radiation therapy. Dermrad™ selected the Mobetron because of its ability to provide desirable cosmetic outcomes for patients in an office setting, and potentially reduce the need for invasive skin cancer surgeries. IntraOp plans to install the Mobetron within the next 30 days.
